RAPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $20,456.44

RAPT Therapeutics Insider Trading History Chart

RAPT Therapeutics Share Price & Price History

^$0.83

▲ +0.0176 (2.18%)

As of 12/20/2024 06:51 PM ET

Days: 30 | 90 | 365

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis

From Stansberry Research | Ad

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.

RAPT Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/5/2024	Dirk G Brockstedt	Insider	Sell	898	$22.78	$20,456.44	27,820
12/21/2023	William Ho	Insider	Sell	2,500	$21.68	$54,200.00	15,020
11/28/2023	William Ho	Insider	Sell	1,500	$13.72	$20,580.00	17,520
10/3/2023	William Ho	Insider	Sell	2,500	$15.77	$39,425.00	18,789
8/18/2023	William Ho	Insider	Sell	2,500	$18.92	$47,300.00	21,289
4/19/2023	William Ho	Insider	Sell	5,000	$18.88	$94,400.00	20,992
3/14/2023	Wendye Robbins	Director	Buy	2,500	$18.99	$47,475.00	14,900
3/7/2023	William Ho	Insider	Sell	5,000	$29.62	$148,100.00	25,532
1/24/2023	William Ho	Insider	Sell	5,000	$30.00	$150,000.00	30,072
1/19/2023	William Ho	Insider	Sell	5,000	$25.56	$127,800.00	35,072
1/5/2023	Dirk G Brockstedt	Insider	Sell	742	$21.97	$16,301.74	19,070
12/29/2022	William Ho	Insider	Sell	5,000	$18.03	$90,150.00	37,650
11/28/2022	William Ho	Insider	Sell	5,000	$17.87	$89,350.00	42,650
11/2/2022	William Ho	Insider	Sell	5,000	$22.32	$111,600.00	47,650
10/13/2022	William Ho	Insider	Sell	2,000	$21.52	$43,040.00	52,650
8/30/2022	William Ho	Insider	Sell	2,500	$28.13	$70,325.00	53,035
7/11/2022	William Ho	Insider	Sell	2,000	$19.95	$39,900.00	52,306
5/25/2022	Group Ii Lp Column	Major Shareholder	Buy	1,900	$12.45	$23,655.00	1,236,261
5/23/2022	Group Ii Lp Column	Major Shareholder	Buy	10,236	$12.50	$127,950.00	1,218,648
5/10/2022	Group Ii Lp Column	Major Shareholder	Buy	1,250,000	$10.67	$13,337,500.00	1,208,750
5/10/2022	Rodney Kb Young	CFO	Buy	5,000	$10.53	$52,650.00	10,084
5/10/2022	Wendye Robbins	Director	Buy	4,500	$11.24	$50,580.00	13,800
5/4/2022	Dirk G Brockstedt	Insider	Sell	720	$15.05	$10,836.00	19,812
4/11/2022	Dirk G Brockstedt	Insider	Sell	2,647	$23.05	$61,013.35	19,812
4/6/2022	William Ho	Insider	Sell	3,000	$22.96	$68,880.00
3/11/2022	Dirk G Brockstedt	Insider	Sell	2,648	$23.91	$63,313.68
2/28/2022	William Ho	Insider	Sell	3,000	$18.79	$56,370.00
2/11/2022	Dirk G Brockstedt	Insider	Sell	2,647	$22.47	$59,478.09
1/13/2022	William Ho	Insider	Sell	3,000	$30.67	$92,010.00
1/11/2022	Dirk G Brockstedt	Insider	Sell	2,648	$32.16	$85,159.68
1/5/2022	William Ho	Insider	Sell	2,000	$40.00	$80,000.00

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

SEC Filings (Institutional Ownership Changes) for RAPT Therapeutics (NASDAQ:RAPT)

99.09% of RAPT Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

RAPT Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	39,729	$79K	0.0%	+277.2%	0.114%
11/15/2024	Barclays PLC	39,729	$79K	0.0%	+277.2%	0.114%
11/15/2024	Jane Street Group LLC	66,515	$0.13M	0.0%	-66.9%	0.191%
11/15/2024	Readystate Asset Management LP	18,074	$36K	0.0%	N/A	0.052%
11/15/2024	Redmile Group LLC	504,532	$1.01M	0.1%	-6.0%	1.446%
11/15/2024	Point72 Asset Management L.P.	525,221	$1.06M	0.0%	-25.7%	1.505%
11/14/2024	PDT Partners LLC	36,998	$74K	0.0%	-62.2%	0.106%
11/14/2024	Walleye Capital LLC	101,163	$0.20M	0.0%	-12.6%	0.290%
11/12/2024	Charles Schwab Investment Management Inc.	70,946	$0.14M	0.0%	-65.9%	0.203%
11/4/2024	Los Angeles Capital Management LLC	201,439	$0.41M	0.0%	+138.1%	0.577%
10/10/2024	Exchange Traded Concepts LLC	89,076	$0.18M	0.0%	+244.7%	0.255%
9/16/2024	Point72 DIFC Ltd	8,697	$27K	0.0%	-83.1%	0.025%
8/19/2024	Point72 Asset Management L.P.	707,300	$2.16M	0.0%	+176,725.0%	2.027%
8/16/2024	Algert Global LLC	47,483	$0.15M	0.0%	-11.9%	0.136%
8/15/2024	The Manufacturers Life Insurance Company	25,325	$77K	0.0%	-30.0%	0.073%
8/15/2024	AQR Capital Management LLC	88,373	$0.27M	0.0%	N/A	0.253%
8/14/2024	Squarepoint Ops LLC	107,994	$0.33M	0.0%	N/A	0.309%
8/14/2024	Cubist Systematic Strategies LLC	295,241	$0.90M	0.0%	+826.4%	0.846%
8/14/2024	Point72 DIFC Ltd	8,697	$27K	0.0%	-83.1%	0.025%
8/12/2024	XTX Topco Ltd	35,480	$0.11M	0.0%	N/A	0.102%
8/9/2024	Renaissance Technologies LLC	203,900	$0.62M	0.0%	+108.1%	0.584%
8/9/2024	Dimensional Fund Advisors LP	331,876	$1.01M	0.0%	-40.4%	0.951%
8/8/2024	Federated Hermes Inc.	796,080	$2.43M	0.0%	+188.7%	2.281%
8/6/2024	Acadian Asset Management LLC	467,182	$1.42M	0.0%	+4,183.3%	1.339%
8/6/2024	Los Angeles Capital Management LLC	84,586	$0.26M	0.0%	+66.2%	0.242%
7/26/2024	Bank of New York Mellon Corp	114,590	$0.35M	0.0%	+24.0%	0.328%
7/20/2024	Hennion & Walsh Asset Management Inc.	48,525	$0.15M	0.0%	+8.6%	0.139%
5/16/2024	Kingdon Capital Management L.L.C.	1,500,000	$13.47M	1.5%	+55.3%	4.298%
5/16/2024	Redmile Group LLC	662,398	$5.95M	0.2%	+80.6%	1.898%
5/15/2024	Price T Rowe Associates Inc. MD	2,028,166	$18.21M	0.0%	-40.6%	5.811%
5/14/2024	EntryPoint Capital LLC	17,907	$0.16M	0.1%	N/A	0.051%
5/10/2024	Acadian Asset Management LLC	10,907	$97K	0.0%	N/A	0.031%
5/10/2024	Vanguard Group Inc.	2,492,850	$22.39M	0.0%	+21.2%	7.163%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	12,652	$0.11M	0.0%	-38.6%	0.036%
4/29/2024	China Universal Asset Management Co. Ltd.	6,602	$59K	0.0%	+65.8%	0.019%
4/19/2024	Denali Advisors LLC	32,600	$0.29M	0.1%	N/A	0.094%
4/5/2024	Los Angeles Capital Management LLC	50,894	$0.46M	0.0%	+442.7%	0.146%
3/18/2024	Kingdon Capital Management L.L.C.	965,828	$24M	3.0%	+19.9%	2.775%
2/26/2024	Perceptive Advisors LLC	2,139,950	$53.18M	1.2%	+11.4%	6.221%
2/15/2024	Octagon Capital Advisors LP	292,000	$7.26M	1.2%	N/A	0.849%
2/15/2024	Great Point Partners LLC	1,099,753	$27.33M	4.7%	-24.6%	3.197%
2/14/2024	Braidwell LP	389,300	$9.67M	0.4%	-64.0%	1.132%
2/14/2024	Artia Global Partners LP	19,638	$0.49M	0.1%	N/A	0.057%
2/14/2024	CenterBook Partners LP	31,447	$0.78M	0.1%	N/A	0.091%
2/13/2024	Rafferty Asset Management LLC	91,553	$2.28M	0.0%	-6.7%	0.266%
2/12/2024	TD Asset Management Inc	117,618	$2.92M	0.0%	-23.4%	0.342%
2/12/2024	Chesapeake Capital Corp IL	10,212	$0.25M	0.2%	N/A	0.030%
2/7/2024	TimesSquare Capital Management LLC	504,340	$12.53M	0.2%	N/A	1.466%
2/6/2024	Charles Schwab Investment Management Inc.	234,439	$5.83M	0.0%	+5.7%	0.682%
2/6/2024	Los Angeles Capital Management LLC	9,378	$0.23M	0.0%	N/A	0.027%
2/6/2024	Swiss National Bank	44,000	$1.09M	0.0%	-10.4%	0.128%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	3,919	$97K	0.0%	-22.9%	0.011%
1/24/2024	China Universal Asset Management Co. Ltd.	3,981	$99K	0.0%	+347.8%	0.012%
1/12/2024	SG Americas Securities LLC	9,801	$0.24M	0.0%	N/A	0.028%
1/5/2024	Exchange Traded Concepts LLC	7,190	$0.18M	0.0%	+34.0%	0.021%
12/18/2023	Vanguard Group Inc.	2,023,305	$33.63M	0.0%	+3.9%	5.882%
12/6/2023	Citigroup Inc.	41,660	$0.69M	0.0%	-6.5%	0.121%
12/1/2023	Euclidean Capital LLC	657,899	$10.93M	2.4%	+15.2%	1.912%
11/15/2023	Redmile Group LLC	427,490	$7.11M	0.3%	-1.0%	1.244%
11/15/2023	Kingdon Capital Management L.L.C.	805,828	$13.39M	1.5%	-19.4%	2.345%
11/14/2023	Braidwell LP	1,082,512	$17.99M	0.6%	+10.0%	3.151%
11/14/2023	Schonfeld Strategic Advisors LLC	135,045	$2.24M	0.0%	+75.4%	0.393%
11/14/2023	Fred Alger Management LLC	85,775	$1.43M	0.0%	-45.9%	0.250%
11/14/2023	Profund Advisors LLC	16,734	$0.28M	0.0%	-27.8%	0.049%
11/13/2023	Algert Global LLC	61,991	$1.03M	0.0%	-17.8%	0.180%
11/13/2023	FMR LLC	4,499,293	$74.78M	0.0%	+7.4%	13.095%
11/13/2023	Rafferty Asset Management LLC	98,159	$1.63M	0.0%	-22.9%	0.286%
11/9/2023	Citigroup Inc.	41,660	$0.69M	0.0%	-6.5%	0.121%
11/8/2023	Swiss National Bank	49,100	$0.82M	0.0%	+9.6%	0.143%
11/7/2023	Barclays PLC	53,651	$0.89M	0.0%	-16.7%	0.156%
10/27/2023	Hennion & Walsh Asset Management Inc.	40,565	$0.67M	0.0%	+89.5%	0.118%
10/27/2023	TD Asset Management Inc	153,618	$2.55M	0.0%	+67.4%	0.447%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	20,547	$0.34M	0.0%	-5.6%	0.060%
10/18/2023	Exchange Traded Concepts LLC	5,366	$89K	0.0%	-18.7%	0.016%
9/21/2023	Barclays PLC	64,436	$1.21M	0.0%	+28.8%	0.188%
8/24/2023	Perceptive Advisors LLC	2,288,493	$42.80M	1.2%	-0.1%	6.661%
8/15/2023	Braidwell LP	984,400	$18.41M	0.6%	N/A	2.866%
8/14/2023	Cormorant Asset Management LP	325,000	$6.08M	0.3%	-50.0%	0.946%
8/14/2023	Great Point Partners LLC	1,465,151	$27.40M	5.4%	+8.1%	4.265%
8/14/2023	Deep Track Capital LP	1,004,561	$18.79M	0.9%	+75.9%	2.924%
8/10/2023	Profund Advisors LLC	23,181	$0.43M	0.0%	+11.3%	0.067%
8/9/2023	TD Asset Management Inc	91,787	$1.72M	0.0%	-1.8%	0.267%
8/8/2023	Candriam S.C.A.	313,262	$5.86M	0.0%	-5.2%	0.912%
8/3/2023	Los Angeles Capital Management LLC	28,748	$0.54M	0.0%	-68.5%	0.084%
8/3/2023	Barclays PLC	64,436	$1.21M	0.0%	+28.8%	0.188%
8/3/2023	Bank of New York Mellon Corp	94,565	$1.77M	0.0%	+1.7%	0.275%
7/20/2023	Exchange Traded Concepts LLC	6,599	$0.12M	0.0%	N/A	0.019%
7/14/2023	Cheyne Capital Management UK LLP	20,000	$0.37M	1.4%	N/A	0.058%
5/16/2023	Great Point Partners LLC	1,355,151	$24.87M	4.9%	-5.7%	3.946%
5/16/2023	Boxer Capital LLC	300,000	$5.51M	0.3%	N/A	0.873%
5/15/2023	Kingdon Capital Management L.L.C.	875,984	$16.07M	3.0%	-0.5%	2.555%
5/12/2023	Profund Advisors LLC	20,823	$0.38M	0.0%	N/A	0.061%
5/11/2023	FMR LLC	4,455,840	$81.77M	0.0%	+50.9%	12.996%
5/11/2023	Citigroup Inc.	111,116	$2.04M	0.0%	+29.2%	0.324%
5/9/2023	California State Teachers Retirement System	36,450	$0.67M	0.0%	+3.0%	0.106%
5/8/2023	Federated Hermes Inc.	17,509	$0.32M	0.0%	N/A	0.051%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	5,083	$93K	0.0%	+683.2%	0.015%
5/4/2023	Barclays PLC	50,034	$0.92M	0.0%	-37.2%	0.146%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	16,688	$0.31M	0.0%	+40.9%	0.049%
5/4/2023	Los Angeles Capital Management LLC	91,373	$1.68M	0.0%	-24.5%	0.266%

Data available starting January 2016

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. RAPT Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company

Today's Range

Now: $0.83

$0.80

$0.88

50 Day Range

MA: $1.51

$0.81

$3.10

52 Week Range

Now: $0.83

$0.79

$27.35

Volume

707,348 shs

Average Volume

731,331 shs

Market Capitalization

$28.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.07

Who are the company insiders with the largest holdings of RAPT Therapeutics?: RAPT Therapeutics' top insider shareholders include:
William Ho (Insider)
Dirk G Brockstedt (Insider)
Wendye Robbins (Director)
Learn More about top insider investors at RAPT Therapeutics.
Who are the major institutional investors of RAPT Therapeutics?: RAPT Therapeutics' top institutional investors include:
Point72 Asset Management L.P. — 1.50%
Redmile Group LLC — 1.45%
Los Angeles Capital Management LLC — 0.58%
Walleye Capital LLC — 0.29%
Exchange Traded Concepts LLC — 0.26%
Charles Schwab Investment Management Inc. — 0.20%
Learn More about top institutional investors of RAPT Therapeutics stock.
Which institutional investors are selling RAPT Therapeutics stock?: During the last quarter, RAPT stock was sold by these institutional investors:
Point72 Asset Management L.P.
Charles Schwab Investment Management Inc.
Jane Street Group LLC
PDT Partners LLC
Redmile Group LLC
Walleye Capital LLC
Which institutional investors are buying RAPT Therapeutics stock?: During the previous quarter, RAPT stock was bought by institutional investors including:
Los Angeles Capital Management LLC
Exchange Traded Concepts LLC
Barclays PLC
Barclays PLC
Readystate Asset Management LP